Micot Pharma Debuts MT200605 Huntington’s Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases

Micot Pharma Debuts MT200605 Huntington’s Disease Research in a Poster Presentation at MDS 2026 and Expands Development into Neurodegenerative Diseases

Hong Kong, Oct 12, 2026 – (ACN Newswire) – The International Congress of Parkinson’s Disease and Movement Disorders (MDS 2026) was held in Seoul, South Korea, from October 4 to 8, 2026. Micot Pharma (2335.HK) presented, for the first time in an electronic poster, nonclinical findings in Huntington’s disease (HD) and Phase I clinical results in healthy volunteers for its independently developed drug candidate MT200605…
Read More

Zaļā Josta - Reklāma